SOD1 and type 1 diabetes mellitus: The administration of silymarin to the diabetic rats resulted in no changes in the serum GPx activity in comparison to the serum of the T1DM rats; thus, its activity remained significantly lower than in the serum of the NDM rats, and, as it was observed in the SOD activity, the doses did not differ among themselves (Figure 2F).